Archives for March 17, 2015

Dispatches from DCAT

Message is clear: Europe is in trouble in terms of pharma growth, experts say

The European pharma market isn’t likely to deliver much growth over the next five years as generic markets commoditize, IMS Health VP Graham Lewis warned participants at the DCAT (Drug, Chemical and Associated Technologies) conference on Monday.

$100m Big Pharma-backed VC fund to focus on dementia research

Biogen Idec, GlaxoSmithKline, Johnson & Johnson, Lilly and Pfizer have all committed to investing in the $100m venture capital fund, alongside Alzheimer’s Research UK and the UK government.

Animal rights protests have had little impact on preclinical services sector say CROs

Animal rights protests have not hurt the non-clinical services sector according to leading CROs which say vital drug development work has continued.

NSF publishes first US standard for pharmaceutical excipients

NSF International has published a new standard and developed an auditing program that can help pharma companies verify regulatory compliance and strengthen safety and quality across their excipient supply chain.